BackClaritev Overview
Claritev Corporation

Claritev Target Price

See Claritev's analyst price targets ($48) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$23.5

Average Target Price

$48.25105.3% upside

4 analysts in the last 4 months

High: $73 | Low: $37

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-20BarclaysGlen Santangelo$4070.2% upsideOpen
2026-08-12Piper SandlerJessica Tassan$73210.6% upsideOpen
2026-08-10Canaccord Genuity$4383% upsideOpen
2026-07-21Canaccord Genuity$3757.4% upsideOpen
2026-06-03Piper Sandler$61159.6% upsideOpen
2026-04-24Barclays$2819.1% upsideOpen
2026-02-24Wells FargoStan Berenshteyn$3027.7% upsideOpen
2026-02-24Guggenheim$3861.7% upsideOpen
2026-01-08Wells FargoStan Berenshteyn$3340.4% upsideOpen

Claritev (CTEV) FAQ

The latest target price for CTEV is $48. Investors often review this figure alongside Claritev's historical trend and sector peers before judging valuation or financial health.

Claritev trades near $23.5 while the consensus target sits at $48 (105.3% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CTEV's target price ($48), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Claritev's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.